Weiss Multi Strategy Advisers LLC Enanta Pharmaceuticals Inc Transaction History

Weiss Multi Strategy Advisers LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $1.37 Million - $1.78 Million	-30,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $1.14 Million - $1.4 Million	30,000	30,000 $1.4 Million

107

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $155M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.